-
Treatment Failure Event Categories Reveal Progressive Increases in Disease and Economic Burden Among Patients With Major Depressive Disorder
Sep 9, 2025, 16:22 PM -
Real-World Healthcare Resource Utilization and Related Costs Associated With Bladder Cancer in the Brazilian Private Market
Sep 9, 2025, 16:22 PM -
Real-World Evidence From Community Oncology: Assessing Secular Trends in Ovarian Cancer Diagnoses From 2014 to 2024
Sep 9, 2025, 16:22 PM -
A Decade in Decision Making: Reviewing Trends in STAS by NICE in Different Disease Areas
Sep 9, 2025, 16:22 PM -
Economic Burden Utilities and Cost-Effectiveness of the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC): A Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
Association Between Objective Response and Overall Survival in BRAF V600e-Mutant Metastatic Colorectal Cancer: An Analysis of the BEACON CRC Trial
Sep 9, 2025, 16:22 PM -
Evaluating the Performance of a Supervised Artificial Intelligence Model in Screening Abstracts for Oncology-Focused Targeted Literature Reviews
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Second-Generation Colon Capsule Endoscopy for Investigation of the Colon Through Direct Visualization
Sep 9, 2025, 16:22 PM -
Descriptive Comparison of Patient Characteristics and Treatment Patterns in Metastatic NSCLC: US and France Cohorts to Inform Transportability
Sep 9, 2025, 16:22 PM -
The Epidemiology Burden and Management of Chronic Hand Eczema in Adolescents: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Evidence of Mapping Malpractice? A Review of Mapping Algorithm Usage in NICE Health Technology Appraisals
Sep 9, 2025, 16:22 PM -
Preliminary Real-World Results of a Community Pharmacy-Based Intervention in COPD: Evidence From the Chronic Diseases From A to Z Program
Sep 9, 2025, 16:22 PM -
Epidemiology and Institutional Treatment Distribution of Patients With Myelofibrosis (MF) in Germany: Insights From a Real-World Evidence Study
Sep 9, 2025, 16:22 PM -
Institutional Trends and Healthcare Resource Utilization in Real-World NMIBC and MIBC Treatment in Germany
Sep 9, 2025, 16:22 PM -
First-Trimester Screening for Preterm Pre-Eclampsia in the United Kingdom: A Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
Costs Associated With the Administration, Postinfusion Monitoring, and Management of Adverse Events (AEs) Related to Novel Drugs for Second-Line (2L+) Treatment of Small-Cell Lung Cancer (SCLC)
Sep 9, 2025, 16:22 PM -
Scoping the Future: Using NICE Scopes to Inform PICO Prediction for EU Joint Clinical Assessment
Sep 9, 2025, 16:22 PM -
Epidemiological Burden of Osteoarthritis in Eastern, Central, and Western Europe Between 1990 and 2021
Sep 9, 2025, 16:22 PM -
Optimization of the EVAR Pathway: An Integrated Organizational Model for Clinical Efficiency and Economic Sustainability
Sep 9, 2025, 16:22 PM -
Development of an LLM-Based Computable Phenotype for Pediatric Lymphoma Subtypes Using Structured and Unstructured Electronic Medical Record Data
Sep 9, 2025, 16:22 PM
